IBIO
iBio, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$58.55M
P/E Ratio
—
EPS
$-1.00
Beta
1.36
52W High
$3.82
52W Low
$0.56
50-Day MA
$2.22
200-Day MA
$1.55
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About iBio, Inc. Common Stock
iBio, Inc., a biotech company, provides contract development and manufacturing services to outside partners and customers in the United States. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | 300,000 |
| Gross Profit (TTM) | 300,000 |
| EBITDA | $-24.74M |
| Operating Margin | -8491.00% |
| Return on Equity | -70.20% |
| Return on Assets | -37.00% |
| Revenue/Share (TTM) | $0.02 |
| Book Value | $1.88 |
| Price-to-Book | 1.04 |
| Price-to-Sales (TTM) | 195.18 |
| EV/Revenue | 28.89 |
| EV/EBITDA | -1.59 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 14.30% |
| Shares Outstanding | $36.14M |
| Float | $27.34M |
| % Insiders | 2.36% |
| % Institutions | 49.26% |
Historical Volatility
HV 10-Day
47.92%
HV 20-Day
55.28%
HV 30-Day
95.83%
HV 60-Day
90.23%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($5.37 target)
6
BuyData last updated: 4/30/2026